Stocky Balboa

Stocky Balboa

Morning brief — 2026-05-11

🥊 The shortlist is split between broken stories and discounted ones, and that's the whole tape right now — macro compression is handing you cheap entries on fundamentally intact names while the wobbly theses (CI, BAC, EA) are cheap for a reason. Half the board got hit by sector fear or trade noise, not earnings misses. That's a buy-zone environment for the right names, not a bunker-down one. Watch the 200DMA across the board; that's where the knife-catch risk separates from the discount risk.

Three names today: DE first — earnings Thursday May 15, street high PT, tariff exposure, do not add size before that print or you're guessing. EQT is the clearest setup: CEO dropped $2.16M of personal money at $43 while it was getting sold, record FCF, $4B buyback — 17% pullback with thesis intact is the trade. ACGL rounds it out: one bad quarter dressed up as a broken business; 22% gap to mean PT at under 11x forward says otherwise.

Portfolio snapshot

Total value: $311,440.31

Account Balance Positions
ROTH IRA $10,432.32 3
Individual - TOD $76,065.59 3
WALMART RSU $58,298.82 0
Individual - TOD $166,643.58 16

Catalyst calendar (next 14d)

Ticker Date When EPS Est Rev Est
DE 2026-05-21 bmo 5.8891 11880700593

Quant pass summary

Shortlist research notes

ACGL — Arch Capital Group Ltd.

Thesis status: intact Confidence: high

Material events (last 14d)

Insider activity (last 90d)

Net direction: quiet (all transactions are compensation-related, no discretionary open-market buys or sells)

Earnings & analysts

News (last 48h)

The dominant narrative is the Q1 earnings miss post-mortem. Multiple outlets and Seeking Alpha articles frame the 8–9% post-earnings pullback as wildfire-driven and one-time rather than structural, with ACGL's 80.9% combined ratio still comparing favorably to the sector average of ~93% in Q1. The Q1 earnings call transcript (published 2026-05-11) shows CEO Grandisson characterizing wildfire losses as within catastrophe budget and reiterating confidence in the pricing environment; KBW noted in a May sector note that post-wildfire property catastrophe rate hardening may improve H2 2026 margins across the specialty insurer group, with ACGL maintained at Outperform and $118 PT.

Flags

Bottom line

Wildfire losses punched a hole in Q1 EPS, but the machine is still running — 80.9% combined ratio, 9% premium growth, book value climbing, and the CEO is sitting on 2.25M shares he hasn't touched on the open market. Don't confuse a bad quarter with a broken business; at ~10.9x NTM earnings with a 22% gap to mean analyst PT, this pullback looks like the setup, not the exit.

AMGN — Amgen Inc.

Thesis status: wobbly Confidence: high

Material events (last 14d)

Insider activity (last 90d)

Net direction: selling (all pre-scheduled) - 2026-05-03 Robert Bradway (CEO) — SELL — 8,500 shares @ $263.40 = $2.24M — via 10b5-1 plan (adopted 2025-11-14, regular monthly cadence) - 2026-04-28 Murdo Gordon (EVP Commercial) — SELL — 5,200 shares @ $268.15 = $1.39M — via 10b5-1 plan (adopted 2025-11-20) - 2026-03-10 Davide Gualandi (CFO) — SELL — 3,100 shares @ $271.50 = $842K — via 10b5-1 plan (adopted 2025-10-08) - 2026-02-14 Bradway (CEO) — SELL — 8,500 shares @ $291.20 = $2.48M — same plan, prior tranche

All four transactions are 10b5-1 scheduled sales at regular intervals — no discretionary selling detected. No insider purchases in the 90-day window.

Earnings & analysts

News (last 48h)

Amgen's post-earnings ~7% drop continues to linger in coverage, with analysts split between acknowledging the clean Q1 beat/reaffirmed guidance vs. concern about binary MariTide Phase 2 data due mid-2026. MariTide's Phase 2a showed 14.5% weight reduction at 85 days — below GLP-1 class leaders like tirzepatide — though monthly dosing format is highlighted as a potential differentiator. Sector-wide tariff exposure on API sourcing was flagged; Amgen management characterized current impact as immaterial.

Flags

Red - MariTide binary event risk: Full Phase 2 data due mid-2026, the dominant near-term overhang. Early Phase 2a weight-loss numbers (14.5% at 85 days) trail tirzepatide class benchmarks. If full data disappoints vs. competitors, the obesity-premium narrative evaporates — a known coin-flip event in the next 60–90 days. - Debt load: ~$58B long-term debt from the 2023 Horizon Therapeutics acquisition (debt/equity ~892%). FCF ($2.1B Q1) is healthy but debt service limits flexibility. The market is discounting this deliberately — P/E of 12.9x normalized looks cheap until you remember why.

Green - Tarlatamab first-line SCLC catalyst: PDUFA Oct. 14, 2026, clean Phase 3 data, $800M–$1.2B incremental revenue est. by 2028. Not fully in the price. - 10b5-1 insider sales: All mechanically pre-scheduled months ago — no discretionary bearish signal from management. - Technical setup: 14.5% pullback from 52-week high of $315.47, RSI 35.2 (oversold), within 3% of 200DMA — classic mean-reversion entry zone. Beta of 0.52 limits downside velocity relative to broader market.

Bottom line

AMGN is cheap at 12.9x earnings with a real catalyst queue — tarlatamab label expansion in October and MariTide data mid-year — but the selloff is rational, not a mystery: the market is demanding a risk discount for $58B in debt and a binary obesity bet. The technical entry is attractive and the downside feels limited near the 200DMA, but the MariTide readout in the next 60–90 days is a coin-flip that could extend the pain before the tarlatamab catalyst kicks in. Best suited to a starter position with room to add post-MariTide clarity.

BAC — Bank of America Corporation

Thesis status: wobbly Confidence: medium

Material events (last 14d)

Insider activity (last 90d)

Net direction: selling (scheduled)

Note: Both CFO sales are 10b5-1 scheduled and appear to be part of a systematic liquidation program, not discretionary. CEO activity is entirely tax-withholding on vests — no open-market selling. No open-market discretionary buys observed this period.

Earnings & analysts

News (last 48h)

The dominant near-term overhang is Berkshire Hathaway's continued trimming of its BAC stake — the Q1 2026 13F confirmed roughly a 15% reduction this quarter, extending a drawdown that has run since mid-2024. Buffett remains a top-5 shareholder but the psychological weight of his ongoing exit is real and well-covered. Separately, BAC raised its quarterly dividend 7.7% to $0.28/share on May 5 and raised full-year NII guidance, both of which signal management confidence in the earnings trajectory. Rising consumer delinquency rates across major U.S. banks are being watched as a potential drag on forward credit loss provisions (money banks set aside for expected bad loans).

Flags

Bottom line

Thesis is wobbly on sentiment — Buffett's ongoing exit is a real overhang and credit quality bears watching — but the fundamentals are doing what you want: earnings beat, NII guidance up, dividend raised 7.7%, and 35 analysts with a $62.93 mean PT against a ~$51 spot price; a ~10% pullback to RSI 34 on a bank that just raised its dividend is the kind of setup worth sizing into carefully, not ignoring.

BLK — BlackRock, Inc.

Thesis status: intact Confidence: medium

Material events (last 14d)

Insider activity (last 90d)

Net direction: mixed (routine compensation-plan activity; no alarming cluster)

Note: SEC EDGAR Form 4 data retrieval returned thin filing-level detail; the characterization above is consistent with BlackRock's established pattern of insider disposals being RSU-driven. If discretionary open-market buying appears, that would be a materially different signal — none detected.

Earnings & analysts

News (last 48h)

BlackRock's recent news flow is centered on its continued private-markets buildout — commentary from Fink at a May 2026 conference reiterated that GIP integration is on track and that private credit (loans made directly to companies, bypassing banks) and infrastructure are expected to contribute meaningfully to fee-rate expansion through 2027. A separate story noted BLK is in discussions to expand its tokenized fund (BUIDL, a blockchain-based money market fund) onto additional blockchain networks, extending its first-mover position in asset tokenization. No material negative headlines in the 48-hour window.

Flags

Green - Q1 2026 AUM hit $11.6 trillion — record, driven by iShares ETF inflows and GIP contribution; fee rate held steady despite ETF mix headwinds, which is constructive for margin trajectory. - 2+ analyst target raises post-earnings; no downgrades in 14-day window. - GIP/private markets integration progressing on-track per management commentary; private credit and infrastructure poised to expand fee rate through 2027. - BUIDL tokenized fund expansion signals first-mover durability in asset tokenization, a nascent but high-margin adjacency.

Red / Watch - Insider sales are RSU-vesting-driven (compensation plan disposals), not discretionary — standard for mega-cap executives; low concern weight, but no open-market buying either. - The 8.8% pullback from 52-week high with price sitting within 3% of the 200DMA (200-day moving average, a widely-watched long-term trend line) puts BLK in technical no-man's land — a break below 200DMA would warrant re-evaluation of near-term momentum. - Dividend held flat (not raised) for Q2 — not a red flag per se, but watch for whether buyback cadence compensates.

Bottom line

Thesis intact — BLK just printed a record $11.6T AUM quarter with no cracks in the fee rate, analysts are raising targets not cutting them, and this pullback looks like macro-driven multiple compression (price-to-earnings contraction from broader market risk-off), not a fundamental story break. The $1,254.12 price target implies ~15.6% upside from current spot. The 200DMA is the line in the sand to watch before adding size — hold above it and the technical setup resolves constructively; a close below shifts to wait-and-see.

CI — The Cigna Group

Thesis status: wobbly Confidence: medium

Material events (last 14d)

Note: SEC EDGAR full-text retrieval was partially unresponsive for accession-level detail; material event summary is based on corroborating web search results. Flag accordingly.

Insider activity (last 90d)

Net direction: mixed (mostly selling, with some routine award vestings)

Caveat: Form 4 filings were enumerated from EDGAR but full transaction detail text was not fully retrieved. Patterns above are inferred from Brave search corroboration and filing metadata. Treat as medium-confidence.

Earnings & analysts

News (last 48h)

Cigna has been pulled into sector-wide managed care pressure following UnitedHealth Group's (UNH) dramatic selloff in mid-April 2026, which triggered collateral markdown across the entire managed care group on elevated MLR (medical loss ratio — the percentage of premium revenue paid out in claims; higher MLR compresses margins) fears. CI's post-Q1 results stabilized sentiment somewhat, with management maintaining full-year EPS guidance and emphasizing Evernorth's resilience, but the stock remains pinned near its lows as the market reprices sector-wide medical cost risk. No company-specific negative catalysts in the immediate 48-hour window; news flow is dominated by sector macro (Medicare Advantage rate finalization, CMS prior-authorization rules, broader healthcare policy uncertainty).

10-Q risk factors (highlights)

Flags

Bottom line

CI is a "show me the medical costs aren't running hot in Q2" story right now — the 12.5% haircut is sector fear, not Cigna-specific failure, and at sub-10x forward earnings with guidance intact you're getting a cheap ticket to a name that hasn't actually broken. The $339.75 PT is reasonable on a re-rate to ~11.5x forward earnings. But you need Q2 MLR data (due late July) to confirm the recovery or you're catching a falling knife in a sector still in the penalty box.

CME — CME Group Inc.

Thesis status: intact Confidence: high

Material events (last 14d)

Context on the April 23 earnings 8-K (just outside the 14-day window but directly relevant to the pullback): - Q1 2026 ADV (average daily volume, the core revenue driver) of 29.9M contracts, up 21% YoY - Net revenues $1.63B, +11% YoY; operating margin 62% vs 61% prior year - Diluted EPS $2.71 vs $2.46, +10% YoY - Completed $700M ASR (accelerated share repurchase — company buys back a fixed dollar amount of stock in a compressed timeframe, immediately reducing share count) during Q1 - $1.6B returned to shareholders in Q1 combined (ASR + annual variable dividend) - Balance sheet: $4.7B cash, $3.4B long-term debt

Insider activity (last 90d)

Net direction: selling (all 10b5-1 plan — pre-scheduled, meaning not discretionary)

All sales are explicitly footnoted as executed under Rule 10b5-1 plans (pre-scheduled selling programs insiders file in advance so they can liquidate without timing the market or trading on non-public information). Duffy still holds ~487K shares direct following the April sale, so these are programmatic trims, not exits. No buys on record in the 90-day window.

Earnings & analysts

News (last 48h)

Coverage in the last 48 hours is thin and mostly thematic rather than event-driven. A Yahoo Finance piece asks whether CME is a "good stock to buy" and frames the business around its durable competitive position in derivatives markets; a separate piece slots CME into a "best moat stocks" list alongside dividend compounders. There are no breaking news items, no regulatory actions, no leadership changes, and no M&A rumors in current circulation.

Flags

Bottom line

The fundamentals are clean — 21% volume growth, 10% EPS growth, a $700M buyback just wrapped, and a CEO who still holds nearly half a million shares after his scheduled trim — this 12% pullback from the high with RSI at 39 looks like the market handed you a discount on a business that prints money when volatility is elevated, which isn't going away.

DE — Deere & Company

Thesis status: wobbly Confidence: medium

Material events (last 14d)

Note: SEC EDGAR filing retrieval returned accession numbers that could not be fully parsed for line-item content; supplemented with Brave Search and Finnhub data throughout.

Insider activity (last 90d)

Net direction: selling (routine/compensation-related; no cluster alarm)

Caveat: Full Form 4 line-item detail was partially unavailable from EDGAR retrieval; assessment is medium-confidence.

Earnings & analysts

News (last 48h)

Deere headlines in the 48-hour window center on two themes: tariff exposure and pre-earnings positioning. Multiple outlets note that Deere manufactures equipment in the U.S. but sources steel and components globally, making it a net cost-pressure name under current Section 232/301 tariff regimes (U.S. import duties on steel, aluminum, and Chinese-origin components); analysts debate whether Deere can pass through costs given soft farmer income and already-weak large-equipment order books. Separately, farm-sector sentiment trackers (Farm Bureau, USDA) show large-equipment purchase intent near multi-year lows, reinforcing the revenue-headwind side of the equation heading into the Q2 print.

Flags

Bottom line

Four days from a print that could re-price the full year guide in either direction, the $665 target is the street high not the consensus — confirm your PT source, wait for the May 15 number before adding size, because a guide-cut under tariff pressure would make this a falling knife, not a buy zone.

EA — Electronic Arts

Thesis status: wobbly Confidence: medium

Material events (last 14d)

Note: SEC EDGAR direct filing retrieval for EA's CIK (0000712515) returned limited structured data; the earnings and restructuring details above are sourced from Brave search results and Finnhub news feed.

Insider activity (last 90d)

Net direction: selling

Data quality note: EDGAR Form 4 direct lookup returned no parseable transactions in this session. Insider direction is inferred from Finnhub insider transaction feed and Brave search — treat as medium-confidence, not confirmed tick-by-tick.

Earnings & analysts

News (last 48h)

Post-earnings coverage has centered on EA's disappointing FY2027 bookings outlook, which guided below the street's estimate amid softening live-service revenue (ongoing in-game spending in titles like FC25 and Apex Legends) and uncertainty around the Battlefield franchise relaunch. Several outlets noted the stock has pulled back sharply — consistent with the RSI 15.1 reading — and there is debate among analysts about whether the guidance cut is a conservative reset or a genuine top-line problem. No new product announcements, M&A rumors, or executive changes surfaced in the last 48 hours.

Flags

Bottom line

The RSI is screaming oversold but the signal is clean — EA just guided FY2027 bookings below the street, cut headcount again, and drew zero insider buy interest; this is a compressed valuation on a story that still needs to prove Battlefield and live-services can re-accelerate, so the buy-zone trigger here is a thesis-dependent call, not a free lunch.

EMR — Emerson Electric Co.

Thesis status: wobbly Confidence: high

Material Events (last 14d)

Insider Activity (last 90d)

Net direction: mixed — tax withholding disposals dominant; one discretionary CEO sale flagged

Date Person Role Code Shares Price Value
2026-04-04 Karsanbhai Lal President & CEO S (open-market sale) 22,500 $137.42 $3.09M
2026-04-04 Karsanbhai Lal President & CEO F (tax withholding) 33,206 $137.42 $4.56M
2026-04-04 Baughman Mike outgoing CFO F (tax withholding) 14,040 $137.42 $1.93M
2026-04-25 Baughman Mike outgoing CFO F (tax withholding) 18,748 $135.15 $2.53M
2026-04-04 Krishnan Ram EVP & COO F (tax withholding) 22,656 $137.42 $3.11M
2026-04-04 Johnson Vidya EVP F (tax withholding) 14,870 $137.42 $2.04M
2026-04-04 Pelch Sara VP & General Counsel F (tax withholding) 25,482 $137.42 $3.50M
2026-05-07 Krishnamurthy Ram new CFO A (award) 9,823 $0.00 sign-on equity grant

CEO sale flag: The 22,500-share open-market sale (code "S") on April 4 is discretionary — not a tax withholding. At $137.42, this was $3.09M sold one month before an EPS miss with stock near its highs. The filing does not confirm a pre-scheduled 10b5-1 plan. If unscheduled, a CEO selling $3M ahead of a miss is a yellow flag worth verifying before adding size.

Earnings & Analysts

Firm Prior PT New PT Rating
Goldman Sachs $175 $162 —
Barclays $170 $155 —
Morgan Stanley — $150 Equal Weight (maintained)
UBS $180 $165 —

10-Q Risk Factors (filed 2026-05-07, period ended 2026-03-31)

  1. Tariff & trade policy risk: ~$200M annual headwind from current U.S. tariffs on China imports; pricing and supply chain offsets partially mitigate, but escalation risk remains open.
  2. Macroeconomic / end-market demand: Exposure to capex cycles in oil & gas, chemicals, discrete manufacturing. Asia-Pacific (especially China) softness is an active drag on near-term revenue.
  3. CFO transition risk: Finance leadership change carries execution risk for financial reporting, investor relations, and capital allocation continuity during the transition period.
  4. AspenTech integration risk: Full consolidation underway; synergy targets carry execution risk across operations, culture, and technology platforms.
  5. Cybersecurity risk: Growing OT (operational technology) software and connected device portfolio increases attack surface at customer facilities.
  6. FX risk: ~54% of revenues outside the U.S.; primary exposures to EUR, CNY, GBP.

News Sentiment (last 48–72h)

Tone: cautiously negative post-earnings, floor bids visible

Technical Context (from shortlist brief)

Metric Value
52-week high $155.31 (2026-02-11)
Pullback from 52w high ~12.3%
Current spot (implied) ~$136.14
Distance from 50DMA within 3%
Price target $164.17 (+16.2% upside)
Beta 1.66
Dividend yield 1.87%
P/E (TTM) 38.65x
Market cap ~$72.5B

Green Flags

Red Flags

Bottom Line

EMR is in a structurally credible buy zone — 12% off highs, near 50DMA, $2B buyback in place, guidance midpoint intact — but two specific items need verification before conviction: (1) confirm whether the CEO's April 4 open-market sale was on a pre-scheduled 10b5-1 plan (if not, treat as insider distribution signal); (2) understand whether the CFO change was a planned succession or a performance-driven exit. If both resolve benignly, the $164 PT (16% upside) on a dividend-payer with a buyback floor and a real software ARR story is a credible entry. If the CEO sale was discretionary, reduce target size by half and wait for the new CFO's first public commentary before going full weight.

EQT — EQT Corporation

Thesis status: intact Confidence: high

Material events (last 14d)

Insider activity (last 90d)

Net direction: buying

The February cluster buys are the signal: CEO, CFO, and EVP all bought open-market at ~$43 within the same week when the stock was at multi-month lows. The April dispositions are mechanical RSU tax events, not conviction sells.

Earnings & analysts

News (last 48h)

Natural gas front-month futures rallied ~3.2% on May 9 on near-record LNG export utilization data, with EQT among the leading E&P gainers (Reuters, May 9). This follows a notable post-earnings paradox: EQT beat Q1 estimates by ~18% on FCF, raised full-year guidance, and expanded buybacks — yet the stock pulled back ~8% in the subsequent two weeks on macro risk-off sentiment and a spot gas retreat from $3.80 to ~$3.20/MMBtu (Motley Fool, May 5). EQT's 10-Q (filed May 6) drew coverage for its $532M quarterly debt paydown progress and its explicit flagging of DOE LNG export policy as a headline risk if the current administration reverses approvals for new terminals (Seeking Alpha, May 6).

Flags

Bottom line

This one's bruised but not broken — EQT just posted record FCF, raised guidance $250M, blew out a $4B buyback authorization, and the CEO personally bought $2.16M in stock at $43 while the bears were celebrating; a macro-driven 17% pullback with thesis fully intact is exactly the buy-zone setup the numbers are screaming about, not a reason to flinch.

FANG — Diamondback Energy, Inc.

Thesis status: intact Confidence: high

Material events (last 14d)

Insider activity (last 90d)

Net direction: quiet (all transactions are non-discretionary tax events — no open-market selling)

No cluster selling, no CFO activity, no discretionary open-market buys or sells. The Jan sell by Stice is the only M+S transaction; his 677K share position post-sale signals very high retention.

Earnings & analysts

News (last 48h)

FANG shares fell May 11 as WTI crude (West Texas Intermediate — the U.S. benchmark crude price) traded near the $58–60 range, pressured by OPEC+ supply-increase signals; the move is sector-wide, not company-specific. The stock had initially rallied post-earnings May 6–7 on the $4B buyback announcement and capex discipline. Current price (~$188) sits near the 50-day moving average, with the pullback now approximately 11–12% from the 52-week high — macro crude repricing, not a thesis break.

Flags

Bottom line

You've got a best-in-class Permian operator that just beat earnings, cut its spend, held its production, and doubled its buyback — the 11.7% pullback is WTI dragging the whole sector to the mat, not a fundamental tap-out, and at $188 with a $218 consensus target and $4B buyback working the bid, you're being paid to wait.

FCX — Freeport-McMoRan Inc.

Thesis status: wobbly Confidence: medium

Material events (last 14d)

Note: The 14-day window from 2026-04-27 to 2026-05-11 captured only the dividend declaration and S-8 as new filings; the earnings event itself fell just outside the window (April 22) but is the dominant catalyst driving the current price dislocation and is included for context.

Insider activity (last 90d)

Net direction: selling

A 10b5-1 plan is a pre-scheduled, SEC-approved trading plan executives set up in advance to avoid insider-trading liability — sales under these plans are less alarming than discretionary sales, but a cluster of executives all selling near the same price band still warrants attention. The COO's discretionary sale is the item to watch here.

Earnings & analysts

Note: Analyst data sourced from Finnhub recommendation trends and Brave search; individual PT/date precision is medium confidence — verify before trading on specific levels.

News (last 48h)

Copper futures pulled back roughly 2% on May 10-11 after the US-China trade negotiation tone softened modestly but no concrete tariff relief was announced, keeping pressure on base-metal miners. FCX specifically drew commentary around its Indonesia Grasberg mine (one of the world's largest copper-gold mines, located in Papua, Indonesia — FCX's highest-margin asset), where analysts noted any tariff-driven demand softness hits FCX harder than peers given Grasberg's cost structure ties to realized copper price. No company-specific operational news in the last 48 hours; the stock is trading on macro copper price sentiment.

Flags

Bottom line

The copper thesis isn't broken — Grasberg's still a monster asset and the long-term demand story is intact — but you've got a cluster of insider selling near the top, a guidance trim, a BMO flip to neutral, and a copper market that's sitting on its hands waiting for tariff clarity, so this is a "watch the macro unlock, not a close-your-eyes buy" setup at current levels.

FOXA — Fox Corporation (Class A)

Thesis status: wobbly Confidence: high

Material events (last 14d)

Insider activity (last 90d)

Net direction: mixed (CEO departure transfer + incoming CEO equity grant)

Earnings & analysts

News (last 48h)

Fox Corp stock is trading roughly 16-17% off its 52-week high despite a clean earnings beat and guidance raise — the gap is almost entirely attributable to CEO-transition anxiety, not fundamentals. Viet Dinh, the new CEO, comes from a legal background (former U.S. Assistant AG, Georgetown Law professor) rather than a media operations background, which is the source of Street unease. The simultaneous departure of three independent board members in late April — ahead of the May 1 CEO announcement — is drawing scrutiny about whether the board reshuffling and CEO change are connected to something larger, though all filings state no policy disagreements.

Flags

Bottom line

The business just dropped a 14-cents-per-share earnings beat and raised the full-year guide — but you're buying a governance question mark right now: a new CEO with no media ops experience, three board members who walked out the door before the announcement hit, and a major shareholder (Murdoch) who's now on the exit ramp. The 16.9% pullback is priced on real uncertainty, not noise — this is a "watch the next 30-60 days for strategic clarity" situation before you size in, not a reflexive dip-buy.

GM — General Motors Company

Thesis status: wobbly Confidence: medium

Material events (last 14d)

Insider activity (last 90d)

Net direction: mixed (routine sales, no cluster buying)

Note: thin data here — SEC EDGAR Form 4 search returned partial results. Cross-reference with openinsider.com before weighting heavily.

Earnings & analysts

News (last 48h)

The tariff narrative is dominating GM coverage. Reports from Bloomberg and Reuters (2026-05-09 to 05-11) focus on the auto industry lobbying the White House for tariff carve-outs, with GM cited specifically as among the hardest-hit domestic OEMs (original equipment manufacturers — the big car companies) due to its Mexico production exposure. A secondary thread covers GM's EV (electric vehicle) segment: Ultium platform deliveries are accelerating but still loss-making at the unit level, and analysts are watching whether GM walks back any EV investment targets in the back half of the year. No new product, recall, or legal headline in the last 48 hours.

Flags

Bottom line

The Q1 beat was real, but Barra handed you a $4–5B tariff grenade with the guidance cut, and Wall Street is repricing that risk right now — at ~$79 spot with a $94 target, you're being asked to bet the tariff situation resolves favorably before the market does, which is a macro call more than a business-quality call.

Key data gaps: Form 4 10b5-1 plan status for CEO sale not confirmed (check SEC EDGAR directly for the full filing footnotes); Q2 tariff offset progress is the single largest unknown between now and July earnings.

GRMN — Garmin Ltd

Thesis status: intact Confidence: medium

Material events (last 14d)

Insider activity (last 90d)

Net direction: selling - 2026-02-14 Min Kao (Executive Chairman / co-founder) SELL 50,000 shares @ ~$230 = ~$11.5M - 2026-03-10 Clifton Pemble (CEO) SELL 15,000 shares @ ~$238 = ~$3.57M - 2026-03-20 Douglas Boessen (CFO) SELL 5,200 shares @ ~$241 = ~$1.25M - Aggregate remaining officers/directors: ~8 additional Form 4 sell transactions totaling est. ~$4M across the 90-day window; no Form 4 buys logged.

Note: SEC filings data was partially thin on exact transaction prices — figures above drawn from EDGAR filings cross-referenced with Brave search. Flag applies below.

Earnings & analysts

News (last 48h)

Garmin has been quiet at the company-specific level in the last 48 hours; no fresh press releases or product announcements have surfaced. Broader market attention on the name is focused on the tariff macro backdrop — Taiwan-manufactured electronics remain in the crosshairs of U.S.-China trade policy, and investor concern around input cost pressure has been cited as the primary driver of the ~10% pullback from April highs despite the earnings beat. No negative company-specific catalysts have emerged in this window.

Flags

Bottom line

Thesis intact — the 10% pullback is a tariff-fear discount on a company that just beat earnings and raised guidance, not a fundamental crack, but the cluster of C-suite selling is worth watching before sizing up.

HON — Honeywell International

Thesis status: wobbly Confidence: medium

Material events (last 14d)

Note: SEC EDGAR full-text search returned thin results for the exact filing URLs in this window; the earnings/guidance items above are confirmed via news synthesis and Finnhub data. Treat the precise EPS figures as approximate pending direct 10-Q/8-K verification.

Insider activity (last 90d)

Net direction: selling (moderate, mixed with small acquisitions via option exercises)

Caveat: SEC Form 4 search via EDGAR tool returned limited structured results in this session. The above is sourced from news synthesis + Brave search. Flag this as medium-confidence data — verify Form 4 dates and plan tags on EDGAR directly before trading on it.

Earnings & analysts

Consensus is supportive but has been drifting lower post-earnings.

News (last 48h)

News flow in the last 48 hours is routine/thin — no new M&A announcements, no executive changes, no regulatory actions. The dominant narrative remains the Q1 guidance cut and tariff exposure across Honeywell's industrial and aerospace supply chains. A few outlets note that the stock's ~14% pullback from its 52-week high has brought valuation into a range that longer-term investors find more interesting, though sell-side notes published post-earnings emphasize that macro headwinds (global industrial capex slowdown, tariff drag on imported components) are unlikely to resolve quickly.

Flags

Bottom line

The guidance cut is real and the tariff drag isn't going away fast, but a 14% haircut on a Dow component sitting at RSI 30 with a separation catalyst on the calendar is a "hurt not broken" setup — the question is whether Q2 shows the floor or the trapdoor.

HUBB — Hubbell Incorporated

Thesis status: wobbly Confidence: medium

Material events (last 14d)

Note: The 8-K filing index returned accession numbers but document-level content retrieval was partially limited; material event characterizations above are confirmed via cross-reference with Brave search news results from the past 14 days.

Insider activity (last 90d)

Net direction: mixed (award-driven grants with some open-market sells)

SEC EDGAR returned 15+ Form 4 filings in the 90-day window. Document-level content was thin on parsed transaction tables, but cross-referencing filing dates and the Brave news search yields the following picture:

Note: Thin parsed detail on individual transaction prices/sizes — data confidence here is medium. The absence of a clear discretionary buy cluster means insiders are not providing a strong contrarian signal on the pullback.

Earnings & analysts

News (last 48h)

Hubbell's post-earnings pullback continues to dominate the news cycle. The primary driver cited across multiple sources is management's acknowledgment of tariff-related cost headwinds affecting both its Electrical Solutions segment (wiring devices, lighting, circuit protection) and its Utility Solutions segment (grid infrastructure components), with some uncertainty around the ability to fully pass through input cost increases via pricing. No new company-specific news has emerged in the last 48 hours beyond the ongoing digestion of the April 29 earnings call. Broader sector context: electrical infrastructure and utility-exposed industrials have broadly softened as tariff clarity remains in flux.

Flags

Bottom line

The pullback is real and earned — tariff noise clipped near-term estimates and the market is right to reprice that risk — but at RSI 23 with the dividend intact and the grid-buildout thesis still breathing, this looks more like a thesis-on-pause than a thesis-broken; wait for one more data point (analyst PT stabilization or a management buyback/insider purchase signal) before sizing in full.

KVUE — TIMEOUT (>300s)

LLY — Eli Lilly and Company

Thesis status: wobbly Confidence: medium

Material events (last 14d)

SEC EDGAR searches returned multiple 8-K filings for LLY in the April 28–May 11 window; content above sourced from filings and corroborated by web search results.

Insider activity (last 90d)

Net direction: selling

Note: All sales appear to be 10b5-1-plan executions, consistent with Lilly's standard executive compensation structure. The absence of any open-market buys during a 14% pullback is a mild yellow flag — not alarming, but worth noting.

Earnings & analysts

Finnhub recommendation trends show 30+ Buy ratings, 3 Hold, 0 Sell as of latest pull.

News (last 48h)

LLY shares have stabilized near the $950 range after a post-earnings selloff driven by investor disappointment that full-year guidance was not raised more aggressively despite the Q1 beat. The dominant narrative in the last 48 hours is the pharmaceutical tariff overhang — Lilly manufactures a significant share of its GLP-1 supply (tirzepatide, sold as Mounjaro/Zepbound) domestically in Indiana and Ireland, giving it some structural insulation, but analysts are flagging the Ireland manufacturing base as a tariff risk if pharmaceutical sector carve-outs are not preserved. No new clinical data or regulatory actions have dropped in this window.

Flags

Bottom line

Thesis is wobbly on noise, not broken on fundamentals — the 14% pullback reflects tariff fog and a "not enough" guidance raise, not a crack in the GLP-1 demand story, and with orforglipron's NDA clock now running and 45% revenue growth still printing, the bull case is very much alive at this price.

MRK — Merck & Co., Inc.

Thesis status: wobbly Confidence: medium

Material events (last 14d)

Insider activity (last 90d)

Net direction: selling

Note: All identified insider sales appear to be 10b5-1 pre-scheduled plans. The absence of any open-market buying from insiders while the stock has pulled back 9.6% is a mild yellow flag — insiders are not signaling conviction at current prices, even passively.

Earnings & analysts

News (last 48h)

Merck's stock has remained under pressure following the Q1 guide-down, with trade-press coverage focused on pharmaceutical tariff uncertainty and the IRA negotiation impact on Keytruda's U.S. net pricing beginning in 2026. Morgan Stanley's downgrade (issued post-earnings) is circulating widely and drawing attention to the thesis question of whether Keytruda's growth ceiling is now visible. No new pipeline, M&A, or regulatory news broke in the last 48 hours; the volume of coverage is moderate, not panicked.

Flags

Bottom line

The dip is real but so is the reason for it — a guide cut driven by IRA price negotiation eating into Keytruda's margin and tariff drag that management can't size yet; with one Morgan Stanley downgrade still fresh and zero insider hands going into the cookie jar at these prices, this is a "watch and wait for the dust to settle" situation rather than a clean buy-zone setup.

MTB — M&T Bank Corporation

Thesis status: intact Confidence: medium

Material events (last 14d)

Insider activity (last 90d)

Net direction: mixed (light selling, likely routine)

Note: thin EDGAR Form 4 data returned directly; characterization draws partly on Brave search cross-reference. Flag accordingly.

Earnings & analysts

News (last 48h)

News flow on MTB is quiet in the last 48 hours — no company-specific headlines driving the pullback. The move lower appears to be sector-wide pressure on regional banks (KRE, the SPDR S&P Regional Banking ETF, peers including USB, RF, CFG all showing similar softness), consistent with macro uncertainty around Federal Reserve rate-path expectations and residual credit-quality concerns across the sector rather than any MTB-specific catalyst. No new regulatory actions, no credit event disclosures, no management commentary outside of the earnings call.

Flags

Bottom line

Bread-and-butter regional bank taking a sector-wide gut-punch with no company-specific damage — Q1 held up, guidance intact, dividend untouched — but the thesis needs a manual Form 4 check before you load up, because the insider data leg is thin and a clean buy-zone setup without any C-suite skin in the game is a good setup, not a great one.

NEM — Newmont Corporation

Thesis status: intact Confidence: medium

Material events (last 14d)

Insider activity (last 90d)

Net direction: mixed (compensation-driven RSUs and small open-market activity; no alarming cluster)

Earnings & analysts

News (last 48h)

Newmont's news flow in the last 48 hours is predominantly macro-driven rather than company-specific: gold prices remain elevated on safe-haven demand tied to persistent macro uncertainty and dollar softness, which directly benefits NEM's realized price per ounce and margin profile. No company-specific negative catalysts (operational disruptions, regulatory actions, CEO commentary walking back guidance) surfaced in the Finnhub or Brave feeds. Thin company-specific news in this window is consistent with a post-earnings quiet period — Q1 results absorbed, no near-term catalyst on the calendar.

Flags

Bottom line

Thesis is intact — gold's macro tailwind is doing real work for NEM's margins, Q1 reaffirmed the story, and an 11.5% pullback from the high with no new fundamental damage is exactly the kind of dip that gets you closer to a $144 target, not further from it.

ODFL — Old Dominion Freight Line

Thesis status: wobbly Confidence: medium

Material events (last 14d)

Insider activity (last 90d)

Net direction: selling

Note: Plan status (10b5-1 vs. discretionary) was not confirmed across all filings. If these are discretionary sales rather than pre-scheduled, that adds meaningful weight to the bearish signal. Verify directly on SEC EDGAR Form 4s before treating as a hard flag.

Earnings & analysts

News (last 48h)

LTL freight sector broadly under pressure as tariff uncertainty continues to suppress industrial shipping volumes. ODFL's April tonnage data (per earnings call commentary) showed no material sequential improvement into May. Spot freight rates (prices shippers pay for one-time cargo moves, as opposed to contract rates locked in advance) remain soft across the industry, with ODFL, XPO, and Saia all trading near 52-week lows. No ODFL-specific news in the last 48 hours; the price action appears macro/sector-driven rather than company-specific.

Flags

Bottom line

The 11% pullback and RSI near 29 are real, but this is not a clean oversold bounce setup. ODFL just missed earnings, C-suite was selling into the quarter, and three analysts trimmed targets with no one stepping up to defend the stock in print. The chart is cheap for a reason — the freight cycle needs to turn before this becomes a conviction entry. Watch for a stabilization signal in the May tonnage data (typically drops in earnings commentary or industry surveys mid-June) before adding exposure.

PCAR — Paccar Inc

Thesis status: wobbly Confidence: medium

Material events (last 14d)

Insider activity (last 90d)

Net direction: selling

Note: Absence of any buy-side insider activity across the full C-suite during a meaningful pullback is a yellow flag. Insider sales near recent highs are common at cyclical industrials, but the complete lack of buy-side conviction is worth tracking.

Earnings & analysts

News (last 48h)

Paccar's newsflow is dominated by macro freight-market concerns: Class 8 truck orders remain soft as carriers defer fleet upgrades amid tariff-driven freight volume uncertainty. No company-specific crisis headlines, but sector-level commentary from freight indices (Cass Freight Index, ACT Research) points to a continued demand trough for heavy trucks through at least mid-2026. There is no stock-specific catalyst (no deal, no recall, no regulatory action) in the 48-hour window — the pullback is macro/sector-driven, not idiosyncratic.

Flags

Bottom line

The bones of the PCAR thesis are still there — clean balance sheet, intact dividend, best-in-class margins for a truck OEM — but you're trying to catch a falling knife mid-cycle with insiders who were selling at $100+ and JPMorgan just downgrading the name; RSI 23 is a technical setup, not a fundamental green light, so before adding size, you want to see Class 8 order rates stabilize or a 10b5-1 clarification on those insider sales.

PH — Parker Hannifin Corporation

Thesis status: wobbly Confidence: medium

Material events (last 14d)

Insider activity (last 90d)

Net direction: mixed (selling visible, no confirmed cluster buying)

EDGAR Form 4 search returned filings in the lookback window but full transaction-level data was not fully parsed. Search results and supplemental Brave data indicate:

Earnings & analysts

News (last 48h)

Finnhub news feed for PH in the 48-hour window returned sparse results. Brave search fills the gap: the dominant narrative in the past week centers on PH lowering its full-year organic growth guidance for fiscal 2026, citing customer hesitation in short-cycle industrial markets (factory automation, fluid power) tied to tariff uncertainty and a pause in capital spending by industrial customers in North America. Aerospace (both commercial and defense) remains a positive offset — PH's aerospace segment has been running at high single-digit organic growth — but it is not large enough to fully compensate for weakness in the industrial segments. The pullback from the 52-week high appears to be a direct reaction to the guidance trim, not a sector-wide re-rating.

Flags

Bottom line

The 13.9% cut is a guidance-trim reaction, not a thesis-breaker — aerospace holds, margins hold, but short-cycle industrial is soft and one more cut would flip this from "buy-zone reset" to "falling knife," so size accordingly and watch the June industrial data before adding heavy.

PNC — PNC Financial Services Group

Thesis status: intact Confidence: medium

Material events (last 14d)

Insider activity (last 90d)

Net direction: mixed (mostly plan-based sales; no discretionary cluster buys or sells of note)

Note: All Form 4 sales found were tagged to 10b5-1 plans, which reduces the informational signal — they don't suggest insiders are bailing ahead of bad news. The absence of any open-market buying is neutral, not a red flag.

Earnings & analysts

News (last 48h)

PNC has been caught in a broad regional-bank selloff driven by macro anxiety — tariff escalation fears, slowing loan demand signals, and a flattening yield curve narrative have pressured the sector indiscriminately. There is no PNC-specific negative catalyst in the last 48 hours; the pullback appears sector-driven rather than name-specific. Credit quality commentary from Q1 was stable, with net charge-offs (loans written off as unrecoverable, net of recoveries) at 0.28% — below the industry average — and no guidance revision since the April print.

Flags

Bottom line

Nine-and-a-half percent off the high with RSI at 34 and no company-specific damage — PNC took a sector gut-punch, not a business gut-punch, and Q1 showed the fundamentals are still in the fight.

STZ — Constellation Brands

Thesis status: wobbly Confidence: high

Material events (last 14d)

Insider activity (last 90d)

Net direction: selling

Aggregate CFO sales (90d): ~$6.4M across two tranches before resignation. No disclosed 10b5-1 plan on record for either sale. CEO's lone $325K purchase is directionally positive but dwarfed by CFO exit selling.

Earnings & analysts

News (last 48h)

Argus upgraded to Buy on May 11, citing valuation reset and business simplification post-wine divestiture. STZ showcased new Modelo and Corona variants at a Beer Innovation Summit. Stock among gainers on May 11 as broader markets closed higher, appearing to stabilize after the dual hit of earnings miss + CFO departure.

Flags

Bottom line

The beer brand is fine — Modelo doesn't need a flag on the label — but the CFO selling $6.4M without a scheduled plan and then walking out the door the next day is a yellow-turning-orange flag that a cheap RSI reading alone doesn't clear. Goldman pulling their Buy in the same week signals the 22% drawdown isn't purely a valuation gift; the street PT convergence near $177 is constructive and the Argus upgrade adds a counter-voice, but the leadership vacuum (no interim CFO named) and structural tariff headwind argue for waiting on position sizing until a new CFO is named and the next earnings print confirms whether the tariff impact is stabilizing or widening.

TDY — Teledyne Technologies

Thesis status: intact Confidence: medium

Material events (last 14d)

Insider activity (last 90d)

Net direction: mixed (routine, no alarm pattern)

SEC EDGAR Form 4 data returned thin results for the 90-day window. Brave search cross-check shows no cluster insider buying or selling headlines. The pattern appears quiet-to-mixed, consistent with normal periodic compensation-related transactions.

Earnings & analysts

News (last 48h)

Finnhub and Brave search returned no company-specific breaking news for TDY in the last 48 hours, consistent with a post-earnings drift lower rather than a catalyst-driven selloff. The 9.8% pullback from 52-week high appears tied to the broader defense-sector rotation and macro noise (tariff/budget uncertainty) following Q1 earnings, not a company-specific negative. Teledyne's defense electronics and imaging divisions continue to benefit from multi-year government contract backlog, which has not been publicly challenged.

Flags

Green: - Q1 beat on both revenue and EPS with full-year guidance held intact — the pullback is not tracking a fundamental deterioration - RSI 39.9 at the technical oversold threshold, consistent with indiscriminate sector selling rather than informed distribution - No adverse 8-K events (no exec departures, no accounting flags, no regulatory actions) in the window

Red / Yellow: - Thin insider data: could not confirm or deny material Form 4 activity definitively — worth a manual EDGAR check before sizing up - Macro headwinds: defense budget uncertainty and tariff noise remain sector-level overhangs with no near-term resolution - No analyst upgrades captured post-Q1 — sentiment reiteration (not a catalyst) in the short term

Bottom line

Guidance held, Q1 beat, and the 9.8% hole in the chart has no smoking-gun underneath it — this is the market handing you Teledyne at a 17% discount to analyst PT on macro noise, not a broken story. PT $728.77 aligns tightly with the consensus cluster. The primary caution is thin insider data and the absence of a near-term re-rating catalyst; this is a thesis-intact entry, not a momentum play.

TPR — Tapestry Inc.

Thesis status: wobbly Confidence: medium

Material events (last 14d)

Note: SEC EDGAR direct pull returned sparse structured results; above events sourced via Finnhub news + Brave search cross-reference. Treat as medium-confidence on specifics pending official filing confirmation.

Insider activity (last 90d)

Net direction: selling

Note: Insider transaction data pulled from SEC EDGAR; individual line-item prices are approximated from filing window — confirm exact figures in EDGAR before trading on them. The complete absence of open-market buys across the C-suite is a yellow flag, even with 10b5-1 cover.

Earnings & analysts

Flag for orchestrator: the $162.05 PT cited in the buy-zone setup context appears inconsistent with current analyst consensus. Possible data error, stale figure, or a different price target basis (e.g., a bull-case DCF model). This should be reconciled before sizing any position.

News (last 48h)

Post-earnings coverage has centered on two themes: Coach brand resilience (mid-single-digit comp growth, healthy gross margins) versus the tariff overhang on China-sourced production, which management quantified at ~$50M for the remainder of FY2026. Several outlets noted that Tapestry's accessible-luxury (mid-tier luxury, price points between mass market and ultra-high-end) positioning makes it more vulnerable to consumer trade-down and tariff pass-through than peers like LVMH. Kate Spade's continued underperformance relative to Coach remains an unresolved drag with no clear turnaround timeline disclosed.

Flags

Bottom line

The RSI and pullback numbers say "buy zone" but the fundamentals are flashing caution — tariff headwind is quantified and not fully covered, the Street is cutting targets post-earnings not raising them, and that $162 PT looks like a data ghost; reconcile that number before touching this one.

YUM — Yum! Brands, Inc.

Thesis status: wobbly Confidence: medium

Material events (last 14d)

Note: SEC EDGAR returned filing metadata but full document text for these accession numbers was partially unavailable via the MCP tool; material details above are supplemented with Brave search results from financial press coverage.

Insider activity (last 90d)

Net direction: selling

Caveat: Form 4 search via EDGAR returned metadata but full transaction pricing detail was thin. The sell-side pattern is consistent with routine equity compensation offloads, not a cluster of discretionary sales. No BUY transactions surfaced in the 90-day window.

Earnings & analysts

News (last 48h)

Coverage in the last 48 hours has been thin and routine — no breaking news, no M&A speculation, no regulatory filings. Residual post-earnings commentary notes that Wall Street is watching Taco Bell U.S. SSS as YUM's clearest near-term traffic signal, while KFC International faces a headwind from a strong dollar (YUM derives ~60% of system sales outside the U.S., so USD strength mechanically depresses reported results even when local-currency performance is steady). No activist investor activity or capital structure announcements surfaced.

Flags

10-Q Risk factors (most recent, Q1 2026)

Key risks flagged (not new, but contextually elevated right now):

  1. FX translation risk — With ~60% of system sales international, a strong USD compresses reported revenue and royalty income. The 10-Q specifically flags USD/CNY and USD/EUR as primary exposures; China is a meaningful KFC market.
  2. Highly leveraged balance sheet — YUM carried approximately $11.5B in long-term debt as of Q1 2026 (the result of its "asset-light recapitalization" — a strategy executed 2016–2019 where it sold company-owned restaurants, borrowed heavily, and returned cash to shareholders). At current interest rates, interest expense runs ~$550–575M annually. Free cash flow covers it comfortably, but the leverage leaves little cushion if system sales compress materially.
  3. Franchisee health — YUM is ~98% franchised; if franchisee cash flows deteriorate (higher food costs, labor costs, weak traffic), NNU slows and closures rise. This is the transmission mechanism from macro stress to YUM's P&L.
  4. Tariff/supply chain pass-through — Chicken and beef are meaningful input costs for franchisees. Tariff-driven input cost inflation could squeeze franchisee margins, surfacing indirectly in YUM's results via royalty softness and slower development.

Bottom line

Nine percent off the high with RSI in the 30s and the 200-day right below is a classic "buy-zone setup" on paper, but YUM is handing you two genuine yellow flags — management yanked the EPS guide and KFC International is dragging — so don't mistake a cheap-looking technical setup for a clean fundamental story; this is a "watch the next SSS print closely" situation, not a no-brainer add.

← Dashboard All briefs View on GitHub